Who
Chen Franco-Yehuda
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, DarioHealth; Chief Financial Officer, Pluri.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 28 Mar 2019
- Last trade
- 24 Sep 2026
- Last filed
- 28 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Sep 2026filed 28 Sep 2026 | DRIO DarioHealthMedical Devices | SEC FORM 4 Code A | —95,000 at $0.00 | filing |
| 24 Sep 2026filed 28 Sep 2026 | DRIO DarioHealthMedical Devices | SEC FORM 4 Code A | —95,000 at $0.00 | filing |
| 11 Sep 2025filed 15 Sep 2025 | DRIO DarioHealthMedical Devices | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 15 May 2025filed 15 May 2025 | DRIO DarioHealthMedical Devices | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 18 Sep 2024filed 20 Sep 2024 | PLUR PluriBiotechnology | SEC FORM 4 Code A | —8,413 at $0.00 | filing |
| 23 Jan 2024filed 25 Jan 2024 | PLUR PluriBiotechnology | SEC FORM 4 Code A | —355,000 at $0.00 | filing |
| 10 Sep 2020filed 10 Sep 2020 | PLUR PluriBiotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 28 Mar 2019filed 28 Mar 2019 | PLUR PluriBiotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 28 Mar 2019filed 28 Mar 2019 | PLUR PluriBiotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.